PROMINENT-Eye Ancillary Study (Protocol AD)The purpose of this study is to determine if Pemafibrate (administered to participants as part of the PROMINENT study) prevents the worsening of diabetic retinopathy or reduces the incidence of diabetic macular edema. Recruiting Principal Investigator Eduardo NavajasBody Locations and Systems Diabetic Eye ProblemsArea VancouverAge 18 and above
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema (KESTREL)The purpose of this study is to evaluate the efficacy and safety of brolucizumab in treatment of patients with visual impairment due to diabetic macular edema (DME). Recruiting Principal Investigator Patrick MaBody Locations and Systems Macular Edema, Diabetic Eye ProblemsArea VancouverAge 18 and above
Macular Involvement in Diabetic Retinopathy Evaluated With Swept-Source OCTIn this study capillary changes of patients with different severity levels of diabetic retinopathy will be investigated with non-invasive imaging technology to better understand the process of disease progression. Recruiting Principal Investigator Eduardo NavajasBody Locations and Systems Diabetic Eye ProblemsArea VancouverAge 18 and above
Peripheral Diabetic Retinopathy (DR) Lesions on Ultrawide-field Fundus Images and Risk of DR Worsening Over Time To determine the association between peripheral diabetic retinopathy lesions and the likelihood of diabetic retinopathy worsening or improving over time. Closed for Recruitment Principal Investigator David MaberleyBody Locations and Systems Diabetic Eye Problems, Diabetes - Type 1, Diabetes - Type 2Area VancouverAge 18 and above
